Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Operating Expenses | 9,864 | 1,358 | 12 |
| Operating Income | -9,864 | -1,358 | -12 |
| Other Income | 99 | 0 | 0 |
| Pre-tax Income | -9,766 | -1,358 | -12 |
| Net Income Continuous | -9,766 | -1,358 | -12 |
| Net Income | $-9,766 | $-1,358 | $-12 |
| EPS Basic Total Ops | -0.38 | -0.05 | 0.00 |
| EPS Basic Continuous Ops | -0.38 | N/A | N/A |
| EPS Diluted Total Ops | -0.38 | -0.05 | 0.00 |
| EPS Diluted Continuous Ops | -0.38 | N/A | N/A |
| EBITDA(a) | $-9,826 | $-1,339 | $-12 |